secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharma-Bio Serv, Inc. (PBSV)
CIK:        0001304161
Form:       8-K
Filed at:   2022-02-14T23:59:59+00:00
Accession:  0001654954-22-001566
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharma-Bio Serv revenues fall to $20.1M, posts $2.1M net loss; declares $0.075 special dividend
--------------------------------------------------------------------------------

- FY 2021 revenue $20.1M, down ~$1.4M YoY; net loss $2.1M vs. prior-year net income of $2.0M.
- Net loss driven by $5.2M customer account receivable provision, partially offset by $1.9M PPP loan forgiveness.
- Adjusted net income $1.2M, down ~$0.8M YoY; excludes the receivable provision and PPP forgiveness.
- Board declares special dividend of $0.075/share, payable March 15, 2022 to holders of record Feb 25, 2022.
- Management focusing on U.S. and European markets and value-added M&A for non-organic growth.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1304161/000165495422001566/0001654954-22-001566-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1304161/000165495422001566/pbsv_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-001566

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer